Story perspectives

FDA Approves Bemotrizinol Sunscreen Filter, First in 27 Years

6/16/2026

Summary

Story summary

The U.S. Food and Drug Administration approved bemotrizinol for sunscreens on June 9, 2026, ending a 27-year gap since the 1990s.
The filter offers broad-spectrum UVA/UVB protection, photostability, and minimal skin absorption, allowing use on children six months old.
Manufacturers may start adding bemotrizinol on Aug. 9, 2026 under the Parsol Shield brand, exclusive to DSM-Firmenich for 18 months.
American Academy of Dermatology said the approval expands safe sunscreen options for consumers.

1 of 1

Story summary

The U.S. Food and Drug Administration approved bemotrizinol for sunscreens on June 9, 2026, ending a 27-year gap since the 1990s.
The filter offers broad-spectrum UVA/UVB protection, photostability, and minimal skin absorption, allowing use on children six months old.
Manufacturers may start adding bemotrizinol on Aug. 9, 2026 under the Parsol Shield brand, exclusive to DSM-Firmenich for 18 months.
American Academy of Dermatology said the approval expands safe sunscreen options for consumers.